Centene Corporation (CNC) vs Regeneron Pharmaceuticals, Inc. (REGN)
REGN leads on 8 of 13 compared metrics.
A side-by-side comparison of Centene Corporation and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
CNC
Centene Corporation
$65.19Healthcare
REGN
Regeneron Pharmaceuticals, Inc.
$612.14Healthcare
Total return — CNC vs REGN
growth of $100 · last 24yCNC +4448.1%REGN +2193.5%CNC compounded faster
CNC REGN
CNC vs REGN: by the numbers
- •REGN is the larger company ($63.06B vs $32.19B market cap).
- •REGN is profitable (29.65% net margin) while CNC runs a net loss (-3.25%).
- •CNC grew revenue faster over the past five years (11.48% vs 10.16% CAGR).
- •REGN pays a dividend (0.59% yield) while CNC does not currently pay one.
Which is better, CNC or REGN?
Metric tally: CNC 5 · REGN 8It depends on what you're optimizing for:
GrowthCNC(faster 5Y revenue CAGR)
QualityREGN(higher ROIC)
Valuation
| Metric | CNC | REGN |
|---|---|---|
| P/E ratio | — | 14.92 |
| Forward P/E | 14.49 | 11.30● |
| P/S ratio | 0.16● | 4.42 |
| P/B ratio | 1.51● | 2.10 |
| PEG ratio | — | 3.38 |
| EV / EBITDA | — | 11.43 |
| FCF yield | 19.65%● | 6.30% |
Profitability
| Metric | CNC | REGN |
|---|---|---|
| Gross margin | 14.93% | 84.55%● |
| Operating margin | -3.68% | 24.32%● |
| Net margin | -3.25% | 29.65%● |
| ROE | -30.07% | 14.08%● |
| ROIC | -13.41% | 8.51%● |
Dividends
| Metric | CNC | REGN |
|---|---|---|
| Dividend yield | — | 0.59% |
| Payout ratio | — | 8.45% |
Growth (annualized)
| Metric | CNC | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 11.48%● | 10.16% |
| EPS CAGR (5Y) | 14.68%● | 5.70% |
| FCF CAGR (5Y) | 5.28% | 15.42%● |
| Total return CAGR (5Y) | -1.64% | 3.26%● |
Frequently asked
- Which is better, CNC or REGN?
- It depends on your goal. growth: CNC (faster 5Y revenue CAGR); quality: REGN (higher ROIC). Across all compared metrics, REGN leads 8 to 5.
- Which has grown faster, CNC or REGN?
- Over the past five years, CNC grew revenue faster — CNC at a 11.48% CAGR versus REGN at 10.16%.
- Does CNC or REGN pay a bigger dividend?
- REGN pays a dividend (0.59% yield) while CNC does not currently pay one.
- Is CNC or REGN more profitable?
- REGN runs the higher net margin — CNC at -3.25% versus REGN at 29.65%.
- Which has been the better investment, CNC or REGN?
- Over the past 10-year, CNC delivered the higher annualized total return — CNC at 6.74% versus REGN at 5.19%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Centene P/E ratioRegeneron Pharmaceuticals P/E ratioCentene dividend yieldRegeneron Pharmaceuticals dividend yieldCentene ROERegeneron Pharmaceuticals ROECentene operating marginRegeneron Pharmaceuticals operating marginCentene revenue growthRegeneron Pharmaceuticals revenue growthCentene free cash flowRegeneron Pharmaceuticals free cash flow
Centene & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.